Resources Contact Us Home
Browse by Category: Main > Chemistry
Class Information
Number: 536/24.5
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Carbohydrates or derivatives > Nitrogen containing > N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) > Dna or rna fragments or modified forms thereof (e.g., genes, etc.) > Nucleic acid expression inhibitors
Description: Fragments of DNA or RNA which are effective inhibitors of transcription or translation.

Patents under this class:

Patent Number Title Of Patent Date Issued
8710209 Modulation of HSP47 expression Apr. 29, 2014
8710024 Treatment of influenza Apr. 29, 2014
8710023 Antisense modulation of C-reactive protein expression Apr. 29, 2014
8710021 Inhibition of HRP-3 using modified oligonucleotides Apr. 29, 2014
8703930 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes Apr. 22, 2014
8703929 Compositions comprising siRNA and plasmids Apr. 22, 2014
8703921 Compositions and methods for delivering inhibitory oligonucleotides Apr. 22, 2014
8703735 Antisense antiviral compounds and methods for treating a filovirus infection Apr. 22, 2014
8703732 Composition for enhancing TRAIL sensitivity comprising inhibitors for expression or activity of TIP41 as a target gene of TRAIL sensitizer Apr. 22, 2014
8703731 Sphingosine-bound siRNA Apr. 22, 2014
8703730 Complement antagonists and uses thereof Apr. 22, 2014
8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene Apr. 22, 2014
8692067 Reverse breeding Apr. 8, 2014
8691967 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents Apr. 8, 2014
8691966 RNA containing modified nucleosides and methods of use thereof Apr. 8, 2014
8691965 Oligonucleotides for modulating target RNA activity Apr. 8, 2014
8691964 Method for expanding monocytes Apr. 8, 2014
8691963 Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells Apr. 8, 2014
8691786 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA Apr. 8, 2014
8691785 Compositions and methods for non-parenteral delivery of oligonucleotides Apr. 8, 2014
8691784 MCP-1 binding nucleic acids Apr. 8, 2014
8691783 MicroRNA-24 Apr. 8, 2014
8691782 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton Apr. 8, 2014
8691781 Compositions for treating respiratory viral infections and their use Apr. 8, 2014
8691567 Alternative export pathways for vector expressed RNA interference Apr. 8, 2014
8691500 Device and method for detecting biomolecule Apr. 8, 2014
8686128 Agent for targeting c-Jun mRNA Apr. 1, 2014
8686127 Apoptosis inducer Apr. 1, 2014
8685940 Impaired wound healing compositions and treatments Apr. 1, 2014
8685938 Methods to enhance T-cell mediated immune response Apr. 1, 2014
8685937 Nucleic acid aptamers Apr. 1, 2014
8685727 Regulation of macrophage activation using miR-125b Apr. 1, 2014
8685720 Engineered cellular pathways for programmed autoregulation of differentiation Apr. 1, 2014
8685397 Combination therapy for the treatment of ocular neovascular disorders Apr. 1, 2014
8685368 Polyamides for nucleic acid delivery Apr. 1, 2014
8680259 Method and compositions for the identification of agents that have a potential effect against chronic inflammatory diseases Mar. 25, 2014
8680258 Use of microRNAs to control virus helper nucleic acids Mar. 25, 2014
8680254 Modulation of pre-mRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease Mar. 25, 2014
8680065 Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use Mar. 25, 2014
8680063 RNA interference for the treatment of gain-of-function disorders Mar. 25, 2014
8679750 Methods and compositions for the treatment of Huntington'S disease Mar. 25, 2014
8673875 Method for treating atherosclerosis Mar. 18, 2014
8673873 RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders Mar. 18, 2014
8673871 Compounds and methods for modulating expression ApoB Mar. 18, 2014
8673869 Determinants of sensitivity to chemotherapeutic agents Mar. 18, 2014
8673632 Modulation of apolipoprotein (a) expression Mar. 18, 2014
8673268 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases Mar. 18, 2014
8669418 Means and methods for mediating protein interference Mar. 11, 2014
8669239 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells Mar. 11, 2014
8669238 Use of Kif13A and AP-1 inhibitors for inhibiting melanogenesis Mar. 11, 2014

  Recently Added Patents
Media used in digital high speed inkjet web press printing
Blow moulding machine with compressed air recycling
TRPM8 antagonists and their use in treatments
Method for conductivity control of (Al,In,Ga,B)N
Pre-primed roofing membrane
Phosphor, light emitting apparatus, and liquid crystal display apparatus using the same
Enterprise seamless mobility
  Randomly Featured Patents
Device for the unlocking and locking of doors
Device for measuring translation, rotation or velocity via light beam interference
Femoral portion of a hip joint prosthesis
Method of preparing aldehydes by hydroformylation with a rhodium catalyst and recovery of the rhodium catalyst by extraction
Mount for a protective tubing lamp
Graffiti detection system and method of using the same
Airbag apparatus
Liquid crystal display device with uniform characteristics over whole display area
Vehicle front bumper fascia
Production of hydrogen peroxide